Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...
Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted treatment for ALS.
In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...
Microscopic analysis by Montana scientists has revealed the first detailed structure of the pathogen that causes chronic ...
Brain-Computer Interfaces fascinate the sci-fi and medical communities in equal measure, here's how close the transformative ...
CLEVELAND, Ohio — The Guardians will have a new look when they take the field in 2025 after the club introduced updated ...
News Medical on MSN18h
Largest ALS patient-based iPSC repository opens new frontiers in researchIn a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...
KMOV St. Louis on MSN8h
As Ice Bucket Challenge turns 10, Missouri family plans to donate their bodies for ALS researchA Southern Missouri family says their lives will never be the same after the man they love passed away from Lou Gehrig’s ...
Scientists at deCODE genetics and collaborators have published a study in the Journal of Allergy and Clinical Immunology ...
Alzheimer dementia occurs at higher rates among adults with Down syndrome with a mean onset at age 54.5 and a disease duration of 4.6 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback